13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SC Filed 2022-10-11 Event — SEC 0000919574-22-005902 →

Casdin Capital, LLC Century Therapeutics, Inc. IPSC

Stake: Shares:

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
4 transactions
0 buys · 2 sales · 0 awards/exercises
Issuer Cluster
1 13D/G filings on this issuer
0 other filings besides this one
Filer Track Record
12 filings by this filer
11 other filings in the data moat
Short Interest · settle 2026-07-15
DTC 21.97
28,381,612 shares short · +21.0% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers
1 holder · $5.93M
Point72 Asset Mgmt

Form 4 Insider Transactions · last 365d

DateInsiderRoleTypeSharesPriceValue
2026-06-12 Russotti Gregory officer Sale 2,584 $2.23 $6K
2026-06-12 Carr Douglas officer Sale 1,654 $2.23 $4K
2026-06-11 Pfeiffenberger Brent director, officer F 13,849 $2.24 $31K
2026-06-11 Cowan Chad officer F 358 $2.24 $802

Other Filings by Casdin Capital, LLC

FiledFormIssuerStakeShares
2026-06-09 SCHEDULE 13D/A Standard BioTools Inc. LAB 23.90% 88,783,856 view →
2026-06-04 SCHEDULE 13G BIOLIFE SOLUTIONS INC BLFS view →
2026-05-22 SCHEDULE 13D/A BIOLIFE SOLUTIONS INC BLFS 9.70% 4,757,165 view →
2025-08-13 SCHEDULE BIOLIFE SOLUTIONS INC BLFS 15.00% 7,207,165 view →
2025-03-07 SCHEDULE Tenaya Therapeutics, Inc. TNYA 4.30% 6,732,971 view →
2025-03-04 SCHEDULE STANDARD BIOTOOLS INC. LAB 21.60% 80,864,315 view →
2024-01-09 SC STANDARD BIOTOOLS INC. LAB view →
2023-03-20 SC Absci Corp ABSI view →
2022-11-28 SC Tenaya Therapeutics, Inc. TNYA view →
2020-05-18 SC GenMark Diagnostics, Inc. view →
2020-02-07 SC GenMark Diagnostics, Inc. view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →